Dr Eduardo Lara-torre, MD | |
101 Manning Dr, Chapel Hill, NC 27514-4220 | |
(984) 974-1000 | |
Not Available |
Full Name | Dr Eduardo Lara-torre |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 28 Years |
Location | 101 Manning Dr, Chapel Hill, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427051853 | NPI | - | NPPES |
1578030 | Other | DE | AMERIHEALTH |
0705501 | Other | DE | UNITED HEALTHCARE |
510245GYN | Other | DE | BLUE CROSS BLUE SHIELD |
192346 | Other | DE | COVENTRY |
3261741 | Other | DE | AETNA |
6392 | Other | DE | CHRISTIANA CARE |
2105682 | Other | DE | MAMSI/OPTIMUM CHOICE |
7103636 | Other | DE | CIGNA |
1000022557 | Medicaid | DE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 0101242957 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of North Carolina Hospital | Chapel hill, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
As pharmaceutical companies are held to increasingly aggressive product innovation targets, they rely on contracted partners to help with process innovation in drug formulation and manufacturing.
Ligand Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has granted its partner GlaxoSmithKline plc Breakthrough Therapy designation for Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Countries are narrowing in on a "deal to speed up their response to the next flu pandemic by sharing virus samples in return for access to affordable vaccines," co-chairs of a WHO working group told reporters on Tuesday, Reuters reports.
› Verified 1 days ago
Entity Name | University Of North Carolina At Chapel Hill |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
As pharmaceutical companies are held to increasingly aggressive product innovation targets, they rely on contracted partners to help with process innovation in drug formulation and manufacturing.
Ligand Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has granted its partner GlaxoSmithKline plc Breakthrough Therapy designation for Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Countries are narrowing in on a "deal to speed up their response to the next flu pandemic by sharing virus samples in return for access to affordable vaccines," co-chairs of a WHO working group told reporters on Tuesday, Reuters reports.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Eduardo Lara-torre, MD 5221 Paramount Pkwy Ste 420, Morrisville, NC 27560-5491 Ph: (984) 974-1000 | Dr Eduardo Lara-torre, MD 101 Manning Dr, Chapel Hill, NC 27514-4220 Ph: (984) 974-1000 |
News Archive
As pharmaceutical companies are held to increasingly aggressive product innovation targets, they rely on contracted partners to help with process innovation in drug formulation and manufacturing.
Ligand Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has granted its partner GlaxoSmithKline plc Breakthrough Therapy designation for Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Countries are narrowing in on a "deal to speed up their response to the next flu pandemic by sharing virus samples in return for access to affordable vaccines," co-chairs of a WHO working group told reporters on Tuesday, Reuters reports.
› Verified 1 days ago
George Nowacek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-843-7851 Fax: 540-368-5206 | |
Christine Mirng-en Chu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 919-966-5283 | |
Dr. Mary Elizabeth Schlegel, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: University Of North Carolina Campus Health Service, Cb # 7470, Chapel Hill, NC 27599 Phone: 919-843-6301 Fax: 919-966-6356 | |
Dr. Stuart-allison Moffat Staley, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Department Of Ob/gyn, Chapel Hill, NC 27514 Phone: 919-966-6823 Fax: 919-966-6356 | |
Lauren Nord Tholemeier, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1000 | |
Dr. Linda Van Le, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4996 Fax: 919-843-5515 | |
Erica Lynn O'neill, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Unc Hospitals, Chapel Hill, NC 27514 Phone: 919-843-6301 Fax: 919-966-6356 |